Active Pharmaceutical Ingredients Market to Reach US$185.9 billion by 2020
Study by Transparency Market Research concludes
According to market study published by Transparency Market Research (TMR), the global active pharmaceutical ingredients (API) market stood at US$119.7 billion in 2013. Aided by the increasing abbreviated new drug applications (ANDA), which has fueled the demand for APIs extensively, the global market is projected to expand at a CAGR of 6.50% over the period from 2014 to 2020.
The report, titled “Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020”, determines that the global API market is likely to reach a value of US$185.9 billion by the end of the forecast period.
By type of manufacturing, the captive API manufacturing market dominates the global market. However, the API contract manufacturing market is likely to surpass the former over the forecast period.
Based on drugs, the report projects the market for oncology drugs to post the fastest growth rate during the period of forecast.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.